Manipulating Milestones in Pandemic Times with AGTC’s Sue Washer
The COVID-19 pandemic continues to disrupt biopharma clinical trials, especially those conducted with at-risk patient populations. From patient recruitment to data collection, clinical trials execution became considerably more challenging in 2020. On this episode of The Business Of Biotech, UF startup and UF Innovate | Sid Martin Biotech graduate AGTC CEO Sue Washer gives us a behind-the-scenes look at the creative measures her company took to serve a geographically dispersed clinical patient population and ensure her company met clinical milestones.
Pandemic a Boon for Area’s Biotech Industry
While industries like airlines, hospitality and retail struggled much of 2020, one local sector took off during the COVID-19 pandemic. Alachua’s biotechnology... Read More
Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies for COVID-19 Vaccine Adjuvant
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced entering into a material transfer agreement with Adjuvance Technologies Inc. for use of the adjuvant TQL1055 in the Company’s Terra CoV-2 vaccine against COVID-19.
Alachua’s Life Sciences Ecosystem Raises Over $1.0 Billion in 2020
UF Innovate | Sid Martin Biotech announces the City of Alachua’s life sciences industry has raised more than $1 billion in 2020. The life sciences community has accelerated growth with government grants and contracts, mergers and acquisitions, successful financing rounds, and sales revenue.
Chronic Wound Care Company Clearikon Graduates from UF Innovate | Sid Martin Biotech Program
UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, is pleased to announce that resident company Clearikon has graduated from its program.
COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials
Supporting our troops: an Alachua company works to keep our soldiers safe from COVID-19. Here's what UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), is doing on the front lines of the pandemic.
Harness Pheromones for Sustainable Pest Control
"Without some method of treatment, about 12% of crops globally would be lost to plant parasitic nematodes,” says Karl Cameron Schiller, co-founder and chief operating officer of bio-tech startup Pheronym. To combat these pests, Schiller and his team are developing non-toxic pesticide solutions that pose fewer risks to the environment.
When Entrepreneurship Meets Healthcare: Lessons in Playing the Long Game
One medtech immunotherapy company called Morphogenesis in Tampa, Florida, a UF startup and UF Innovate | Sid Martin Biotech alum, is currently working on one of the highest-stakes medical issues of all: treating cancer.
Ology Bioservices Signs Built-to-Suit Lab Space, Adding 43,000 Square Feet to Headquarters
Avison Young facilitated a 42,500-square-foot lease agreement between Concept Companies and Ology Bioservices, a UF startup and UF Innovate | Sid Martin Biotech alum, for a new built-to-suit lab space on the heels of a federal government contract for the company to expand production capabilities, including vaccines and therapeutics for COVID-19 once finalized.
Emeritus Professor of Anesthesiology Inducted As 2020 National Academy of Inventors Fellow
Richard J. Melker, MD, Ph.D., a distinguished University of Florida Emeritus Professor of Anesthesiology, has been elected to the rank of National Academy of Inventors (NAI) Fellow, the highest professional distinction awarded solely to academic inventors.
